| Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 16.05. | Biovaxys Technology Corp: Biovaxys Technology suspended by CSE | 18 | Stockwatch | ||
| 16.05. | BioVaxys Technology Corp. Announces Failure to File Cease Trade Order | 340 | PR Newswire | VANCOUVER, BC, May 16, 2024 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (the "Company") announces that the Ontario Securities Commission (the "OSC") has... ► Artikel lesen | |
| 16.05. | CSE Bulletin: Suspension - BioVaxys Technology Corp. (BIOV) | 185 | Newsfile | Toronto, Ontario--(Newsfile Corp. - Le 16 mai/May 2024) - Effective immediately, BioVaxys Technology Corp. is suspended pursuant to CSE Policy 3. The suspension is considered a Regulatory Halt as... ► Artikel lesen | |
| 16.05. | Biovaxys Technology Corp: Biovaxys Technology halted at the open | 13 | Stockwatch | ||
| 11.05. | Biovaxys Technology Corp: Biovaxys closes $279,625 second tranche of financing | 3 | Stockwatch | ||
| 11.05. | BioVaxys Technology Corp. Closes SECOND Tranche of Private Placement | 614 | PR Newswire | // THIS PRESS RELEASE IS NOT INTENDED FOR RELEASE OR DISSEMINATION IN THE UNITED STATES //
VANCOUVER, BC, May 10, 2024 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB)... ► Artikel lesen | |
| 04.05. | Biovaxys Technology Corp: Biovaxys closes $333,227 first tranche of placement | 5 | Stockwatch | ||
| 04.05. | BioVaxys Technology Corp. Closes First Tranche of Private Placement | 491 | PR Newswire | // THIS PRESS RELEASE IS NOT INTENDED FOR RELEASE OR DISSEMINATION IN THE UNITED STATES //
VANCOUVER, BC, May 3, 2024 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB)... ► Artikel lesen | |
| 02.05. | BioVaxys Technology Corp. Provides Bi-Weekly MCTO Status Update | 203 | PR Newswire | VANCOUVER, BC, May 2, 2024 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (the "Company") is providing this bi-weekly update on the status of the management... ► Artikel lesen | |
| 30.04. | Biovaxys Technology Corp: Biovaxys Technology appoints Cherry as CFO | 2 | Stockwatch | ||
| 30.04. | Stocks in Play: BioVaxys Technology Corp | 4 | Baystreet.ca | ||
| 30.04. | BioVaxys Technology Corp.: Biovaxys Appoints Christopher Cherry As Chief Financial Officer | 80 | PR Newswire | VANCOUVER, BC, April 30, 2024 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (the "Company") is pleased to announce that it has appointed Christopher Cherry as... ► Artikel lesen | |
| 10.04. | Stocks in Play: BioVaxys Technology Corp | 8 | Baystreet.ca | ||
| 10.04. | BioVaxys Technology Corporation: BIOVAXYS AND SPAYVAC-FOR-WILDLIFE, INC. ANNOUNCE LAUNCH OF FIELD TRIAL FOR LARGE-SCALE IMMUNOCONTRACEPTION IN THE COMMERCIAL AQUATIC FARMING INDUSTRY | 259 | PR Newswire | VANCOUVER, BC, and MADISON, Wis., April 10, 2024 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys") and SpayVac-for-Wildlife, Inc. ("SpayVac") jointly... ► Artikel lesen | |
| 05.04. | BioVaxys Technology Corp. Provides Bi-Weekly MCTO Status Update | 372 | PR Newswire | VANCOUVER, BC, April 4, 2024 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (the "Company") is providing this bi-weekly update on the status of the management... ► Artikel lesen | |
| 03.04. | BioVaxys Technology Corp.: BioVaxys Announces Allowance of DPX Formulation Patent for the United States and Filing of Additional International Patent Applications for Phase 1 DPX SurMAGE | 152 | PR Newswire | VANCOUVER, B.C., April 3, 2024 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or "Company") announced that it has received a Notice of Allowance from... ► Artikel lesen | |
| 22.03. | Biovaxys Technology Corp: Biovaxys arranges $1-million private placement | 8 | Stockwatch | ||
| 22.03. | BioVaxys Technology Corp.: BIOVAXYS ANNOUNCES PLANNED PRIVATE PLACEMENT | 470 | PR Newswire | VANCOUVER, BC, March 22, 2024 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or "the Company") announces that it intends to complete a non-brokered... ► Artikel lesen | |
| 21.03. | BioVaxys Technology Corp. Provides Bi-Weekly MCTO Status Update | 324 | PR Newswire | VANCOUVER, BC, March 21, 2024 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (the "Company") is providing this bi-weekly update on the status of the management... ► Artikel lesen | |
| 08.03. | BioVaxys Technology Corp. Granted Voluntary Management Cease Trade Order | 355 | PR Newswire | VANCOUVER, BC, March 8, 2024 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (the "Company") today announced that the Ontario Securities Commission (the "OSC")... ► Artikel lesen |
Seite:
1 2 3 Weiter >>
| Suchbegriffe der letzen 24 h | Anzahl |
|---|---|
| NEL | 8.139 |
| NVIDIA | 4.591 |
| EVOTEC | 3.962 |
| GAMESTOP | 3.007 |
| TUI | 2.850 |
| PLUG POWER | 2.026 |
| BAYER | 1.956 |
| VOLKSWAGEN | 1.735 |
| RHEINMETALL | 1.658 |
| AIXTRON SE | 1.496 |
| SUPER MICRO COMPUTER | 1.421 |
| BYD | 1.334 |
| BIONTECH | 1.193 |
| DEUTSCHE LUFTHANSA | 1.188 |
| SIEMENS ENERGY | 1.152 |
| JINKOSOLAR | 931 |
| HELLOFRESH | 925 |
| RWE | 861 |
| MERCEDES-BENZ | 851 |
| TESLA | 838 |
| COMMERZBANK | 792 |
| DEUTSCHE BANK | 789 |
| BASF | 770 |
| HEIDELBERGER DRUCK | 721 |
| PORSCHE AG | 707 |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
